Mav: If I recall the discussion correctly, there are 2 companies that were in PIII with immunotherapies at the time of the Cognate announcement (NWBO and another I cannot recall). If I remember correctly, the other company was still a ways away from data lock when I researched them. Thus, I concluded the expansion was for NWBO. JMO.